Studying leftover virus after covid recovery
Part of Infections, Lungs & breathing clinical trials.
This study looks for signs of leftover SARS-CoV-2 virus in people who have fully recovered from COVID-19, including those with ongoing neurological symptoms (like brain fog, fatigue, or nerve pain). It aims to understand why some people have long-lasting symptoms after infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had a positive COVID-19 test (PCR or home test confirmed with a blood test) during your infection.
- You have fully recovered from the initial infection (no current active COVID-19).
- You are either healthy now or have ongoing neurological symptoms (like brain fog, fatigue, nerve pain, or dizziness).
- You are not pregnant, breastfeeding, or within a year after giving birth.
- You are willing to travel to the NIH for an extended hospital stay and to share your data and samples.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET scan to look at inflammation in the body of people with long COVID (symptoms lasting 3+ months after infection). The goal is to understand why symptoms persist and find better ways to help.
This study follows adults who recently recovered from COVID-19 to better understand what happens during recovery and afterward. It may help researchers identify who is at risk for longer-lasting symptoms (often called “PASC”) and what changes over time.
This study uses a special PET scan to look at brain inflammation in people with neurological symptoms after COVID-19. It aims to understand how inflammation might be linked to ongoing problems like brain fog or memory issues.
This study tests whether a drug called pembrolizumab (a type of immunotherapy) can help people with ongoing neurological symptoms after COVID-19. The goal is to see if it is safe and possibly improves symptoms like brain fog, fatigue, and dizziness.
This study looks at what factors may make COVID-19 symptoms or infection effects last after someone has recovered. It also collects certain body samples to better understand why this persistence happens.
This study looks at people with lingering post-COVID symptoms, especially breathing and lung-related findings, using home monitoring and medical tests. It may help researchers understand what’s driving ongoing symptoms and identify patterns that could guide better care.
Hear when a new PASC Post Acute Sequelae of COVID 19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.